Leena Das-Young

Leena Das-Young is currently a Pioneer at Artis Ventures. Prior to this, they were the General Manager & Chief Lunar Officer at Guardant Health from June 2018 to June 2019. Before that, they were the Vice President, Head Late Phase Strategy & Development Group, Oncology at Pfizer from November 2013 to June 2018. In this role, they were responsible for the development of 13 late phase medicines, teams, & clinical programs (>300 trials) from early signs of efficacy/POC through submissions/approval, including lifecycle management (phase 1-4 trials to LOE) in both solid and liquid tumors. Leena has also held positions at Micronoma and ARTIS Ventures.

Leena Das-Young completed their Doctor of Pharmacy (PharmD) at Purdue University in the field of Clinical Pharmacy. Prior to that, they completed their BS Pharmacy at the same school.